TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32713349

Group type: EXPERIMENTAL
Intervention: 3R intervention (two facilitated group education sessions, 44 weeks of medication reminders, motivational text messages, and two coaching calls)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 3R intervention
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (usual clinical care)
Number of subjects: 212
Study: 33685920

Group type: EXPERIMENTAL
Intervention: OPTIMAL programme
Number of subjects: 149

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 149
Study: 35306123

Group type: EXPERIMENTAL
Intervention: Active aiTBS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham aiTBS
Number of subjects: 45
Study: 33234633

Group type: EXPERIMENTAL
Intervention: ERAS protocol adherence
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 192

Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 192
Study: 35231563

Group type: EXPERIMENTAL
Intervention: No motion cohort (cemented tibial component held without motion)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Motion cohort (tibial implant taken through gentle range of motion)
Number of subjects: 64
Study: 34672950

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 11340

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 11340
Study: 32546975

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1μg/kg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Midazolam (0.02 mg/kg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (20 mL intravenous saline)
Number of subjects: 105
Study: 36443695

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure and Response Prevention (VRERP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (standardized CBT)
Number of subjects: 36
Study: 34702164

Group type: EXPERIMENTAL
Intervention: Modified Hospital Elder Life Program (HELP)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Routine care (Control Group)
Number of subjects: 195
Study: 32833758

Group type: EXPERIMENTAL
Intervention: HOPE
Number of subjects: 225

Group type: COMPARATOR
Intervention: NRP
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Both NRP and HOPE
Number of subjects: 225
Study: 34492709

Group type: EXPERIMENTAL
Intervention: 6-month cycling aerobic exercise intervention (thrice weekly, moderate-vigorous intensity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic exercise dose
Number of subjects: 0
Study: 34349367

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided spinal anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Landmark technique spinal anesthesia
Number of subjects: 60
Study: 34633061

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 325
Study: 35839558

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 2400 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34199566

Group type: EXPERIMENTAL
Intervention: AMICOPE intervention (multi-domain group-based intervention)
Number of subjects: 0
Study: 35583273

Group type: EXPERIMENTAL
Intervention: GSK2330811 100 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: GSK2330811 300 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 34937855

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Povidone-iodine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 84

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 84
Study: 32565474

Group type: EXPERIMENTAL
Intervention: Integrated Management of Childhood Illness (IMCI) algorithm and pulse oximeter
Number of subjects: 1804

Group type: COMPARATOR
Intervention: IMCI algorithm only
Number of subjects: 1804
Study: 35941737

Group type: EXPERIMENTAL
Intervention: DMPA‐IM
Number of subjects: 58
Study: 33408274

Group type: EXPERIMENTAL
Intervention: 3-dose schedule (0, 1, and 6 months) of 20 µg rHBV vaccine IM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 4-dose schedule (0, 1, 2 and 6 months) of 20 µg rHBV vaccine IM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Accelerated 3-dose schedule (0, 1, 2 months) of 20 µg rHBV vaccine IM
Number of subjects: 50
Study: 36330694

Group type: EXPERIMENTAL
Intervention: integral physiotherapy
Number of subjects: 60
Study: 33676302

Group type: EXPERIMENTAL
Intervention: Functionality writing task
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Positive appearance writing task
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Stress management reflection task
Number of subjects: 240

Group type: COMPARATOR
Intervention: Image exposure (thin-ideal models)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Active images
Number of subjects: 240

Group type: COMPARATOR
Intervention: Posed images
Number of subjects: 240
Study: 32429738

Group type: EXPERIMENTAL
Intervention: VAR-PE process
Number of subjects: 600

Group type: COMPARATOR
Intervention: VAR
Number of subjects: 600
Study: 35751089

Group type: EXPERIMENTAL
Intervention: Minding the Baby (MTB) intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 250
Study: 32286685

Group type: EXPERIMENTAL
Intervention: Tablet-based intervention with audiovisual presentation on coping strategies
Number of subjects: 1841

Group type: COMPARATOR
Intervention: Control group (usual donation process)
Number of subjects: 1841
Study: 33903923

Group type: EXPERIMENTAL
Intervention: Computer-assisted cryotherapy (C-group) during the first seven postoperative days
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Computer-assisted cryotherapy (C-group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Regular postoperative care (R-group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Computer-assisted cryotherapy (C-group) and Regular postoperative care (R-group)
Number of subjects: 102
Study: 33714741

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4725

Group type: COMPARATOR
Intervention: High burden of HF signs and symptoms (≥3)
Number of subjects: 4725

Group type: COMPARATOR
Intervention: Orthopnea
Number of subjects: 4725

Group type: COMPARATOR
Intervention: Rales
Number of subjects: 4725
Study: 35418431

Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound
Number of subjects: 162

Group type: COMPARATOR
Intervention: night splint
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound + night splint (combined)
Number of subjects: 162
Study: 33307783

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy and exercise (group I)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Exercise only (group II)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy only (group III)
Number of subjects: 120
Study: 32706708

Group type: EXPERIMENTAL
Intervention: Vascular View web-based self-management program (12 months access)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 208
Study: 34732139

Group type: EXPERIMENTAL
Intervention: LPO-system-lozenge with 0.083% H2O2 (B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LPO-system-lozenge with 0.04% H2O2 (C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Listerine rinse (A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo lozenge (D)
Number of subjects: 0
Study: 33168073

Group type: EXPERIMENTAL
Intervention: Mantel–Haenszel method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random intercept model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized estimating equation (GEE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GEE with small sample correction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No center adjustment
Number of subjects: 0
Study: 35817125

Group type: EXPERIMENTAL
Intervention: 4 × 30 s star jumping
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 × 30 s star jumping
Number of subjects: 12

Group type: COMPARATOR
Intervention: Resting control (CONT)
Number of subjects: 12
Study: 34184475

Group type: EXPERIMENTAL
Intervention: Prospecta
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 35581126

Group type: EXPERIMENTAL
Intervention: Pharmacist collaborative prescribing model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual medical prescribing model
Number of subjects: 0
Study: 33963847

Group type: EXPERIMENTAL
Intervention: Risk-scoring model developed using multivariate logistic regression analysis.
Number of subjects: 45558
Study: 32184025

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with immunonutrition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no nutritional intervention)
Number of subjects: 0
Study: 35447039

Group type: EXPERIMENTAL
Intervention: Circular and oscillating breast massage device used for 10 to 15 minutes, three times a day, for 3 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 120
Study: 35554097

Group type: EXPERIMENTAL
Intervention: 250 mg CU+
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 500 mg CU+
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CU+
Number of subjects: 24

Group type: COMPARATOR
Intervention: STE (1900 mg)
Number of subjects: 24
Study: 32457071

Group type: EXPERIMENTAL
Intervention: Cabergoline (dopamine D2 receptor agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 35997834

Group type: EXPERIMENTAL
Intervention: 0.017×0.025-inch stainless-steel archwire (group 1)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.019×0.025-inch stainless-steel archwire (group 2)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.021×0.025-inch β-titanium archwire (group 3)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Groups 2 and 3
Number of subjects: 53
Study: 33933112

Group type: EXPERIMENTAL
Intervention: Early childhood education machine (uniform type) in addition to routine standard treatment and nursing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine standard treatment and nursing
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Early childhood education machine (uniform type)
Number of subjects: 52
Study: 36402276

Group type: EXPERIMENTAL
Intervention: Mobile health application with relational agent
Number of subjects: 243

Group type: COMPARATOR
Intervention: WebMD (control intervention)
Number of subjects: 243
Study: 32830332

Group type: EXPERIMENTAL
Intervention: Polytherapy (Bright Light Therapy + Escitalopram Oxalate)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Monotherapy (Escitalopram Oxalate only)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both treatments (Polytherapy and Monotherapy)
Number of subjects: 112
Study: 32336721

Group type: EXPERIMENTAL
Intervention: Emerging new therapeutic strategies using proprotein convertase subtilisin‐kexin type 9 inhibitors or antisesnse oligonucleotide technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pharmacological therapies (statin, niacin, cholesteryl ester transfer protein)
Number of subjects: 0
Study: 35623543

Group type: EXPERIMENTAL
Intervention: PIPS activation with Irritrol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PIPS activation with CHX
Number of subjects: 60

Group type: COMPARATOR
Intervention: CI with Irritrol
Number of subjects: 60

Group type: COMPARATOR
Intervention: CI with CHX
Number of subjects: 60

Group type: COMPARATOR
Intervention: EDDY with Irritrol
Number of subjects: 60

Group type: COMPARATOR
Intervention: EDDY with CHX
Number of subjects: 60
Study: 33765997

Group type: EXPERIMENTAL
Intervention: Detectable viral load
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Non-suppression of viral load (>1000 copies/mL)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Antiretroviral therapy of ≥1 year
Number of subjects: 328

Group type: COMPARATOR
Intervention: Self-reported better adherence to antiretroviral drugs
Number of subjects: 328
Study: 36303515

Group type: EXPERIMENTAL
Intervention: Midline catheter
Number of subjects: 143

Group type: COMPARATOR
Intervention: Peripheral intravenous catheter
Number of subjects: 143
Study: 36449291

Group type: EXPERIMENTAL
Intervention: Mailed HPV self-sampling kit
Number of subjects: 19734

Group type: COMPARATOR
Intervention: Usual care Papanicolaou screening reminders and outreach (Control)
Number of subjects: 19734
Study: 33605836

Group type: EXPERIMENTAL
Intervention: Cinnamon (3 g capsules)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 35770587

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acupoint Stimulation (TEAS) at PC5 and PC6 acupoints
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (placebo intervention)
Number of subjects: 41
Study: 32726531

Group type: EXPERIMENTAL
Intervention: TY014 (2 mg/kg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: TY014 (20 mg/kg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: TY014
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 35777058

Group type: EXPERIMENTAL
Intervention: 5 mL of 2% mepivacaine (group M)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 90
Study: 35109589

Group type: EXPERIMENTAL
Intervention: Brain Health Champion (BHC) intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Counseling and Education (CE) control
Number of subjects: 20
Study: 32797070

Group type: EXPERIMENTAL
Intervention: Observational-imitative method (OIM)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Descriptive-directive method (DDM)
Number of subjects: 36
Study: 35016790

Group type: EXPERIMENTAL
Intervention: One-per-mil tumescent technique
Number of subjects: 35

Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 35
Study: 33352040

Group type: EXPERIMENTAL
Intervention: Nd2(Ta0.2Sc0.2Sn0.2Hf0.2Zr0.2)2O7
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nd2(Ti0.2Nb0.2Sn0.2Hf0.2Zr0.2)2O7+x
Number of subjects: 0
Study: 35226769

Group type: EXPERIMENTAL
Intervention: Complete Pulpotomy (CP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Partial Pulpotomy (PP)
Number of subjects: 106
Study: 33112463

Group type: EXPERIMENTAL
Intervention: Topical herbal solution (MTS + THS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5% Minoxidil (MTS)
Number of subjects: 24
Study: 35538731

Group type: EXPERIMENTAL
Intervention: High value incentives for providing a benzoylecgonine-negative urine sample
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low value incentives for providing a benzoylecgonine-negative urine sample
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Escalating and resetting incentives
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Fixed incentives
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control condition receiving incentives for providing a urine sample regardless of results
Number of subjects: 34
Study: 33229019

Group type: EXPERIMENTAL
Intervention: Life Goals Programme (LGP) - six weekly group sessions
Number of subjects: 64
Study: 32907801

Group type: EXPERIMENTAL
Intervention: Tapering TNF-inhibitor first
Number of subjects: 189

Group type: COMPARATOR
Intervention: Tapering csDMARD first
Number of subjects: 189
Study: 35751306

Group type: EXPERIMENTAL
Intervention: Thermal blanket
Number of subjects: 38

Group type: COMPARATOR
Intervention: Incubator
Number of subjects: 38
Study: 34600544

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Amodiaquine-artesunate (AS?AQ)
Number of subjects: 641
Study: 35648432

Group type: EXPERIMENTAL
Intervention: Adjunctive Reflectance Confocal Microscopy (RCM)
Number of subjects: 3165

Group type: COMPARATOR
Intervention: Standard therapeutic care (clinical and dermoscopy evaluation)
Number of subjects: 3165
Study: 32580207

Group type: EXPERIMENTAL
Intervention: Long pulse width (LPW) stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Short pulse width (SPW) stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline SCC CMRGlu
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reduction in SCC CMRGlu 6 months post DBS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Machine learning analysis
Number of subjects: 20
Study: 32098536

Group type: EXPERIMENTAL
Intervention: Time-lapse incubator (EmbryoScope™)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Conventional incubator (K‐System G‐185 Flatbed)
Number of subjects: 446
Study: 33942350

Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use
Number of subjects: 2519

Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use (≤ 1 maximum defined daily dose)
Number of subjects: 2519

Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use (> 1 maximum defined daily dose)
Number of subjects: 2519

Group type: COMPARATOR
Intervention: Nonusers of aspirin
Number of subjects: 2519
Study: 32579773

Group type: EXPERIMENTAL
Intervention: Topical platelet gel (PG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline dressing and compression (Control)
Number of subjects: 60
Study: 35046640

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) combined with Femoral Nerve Block (FNB)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB) combined with Sciatic Nerve Block (SNB)
Number of subjects: 88
Study: 33070479

Group type: EXPERIMENTAL
Intervention: MST (100 Hz applied over the vertex)
Number of subjects: 45

Group type: COMPARATOR
Intervention: ECT (bifrontal)
Number of subjects: 45
Study: 36049460

Group type: EXPERIMENTAL
Intervention: Vitametik Impulse (VI)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Educational Program (EP)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Combined VI/EP group
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study: 33546013

Group type: EXPERIMENTAL
Intervention: ECMO combined with CRRT
Number of subjects: 0

Group type: COMPARATOR
Intervention: ECMO
Number of subjects: 0
Study: 32998324

Group type: EXPERIMENTAL
Intervention: Lutein (12 mg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 33292081

Group type: EXPERIMENTAL
Intervention: Topical refrigerant spray (TRS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 35977444

Group type: EXPERIMENTAL
Intervention: Social stimuli (faces)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Non-social stimuli (shapes)
Number of subjects: 590
Study: 33534895

Group type: EXPERIMENTAL
Intervention: Nolasiban 900 mg
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: Nolasiban 100 mg
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: Nolasiban 300 mg
Number of subjects: 1836

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1836
Study: 32738408

Group type: EXPERIMENTAL
Intervention: Positive Health Check intervention in addition to the standard of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 0
Study: 35842289

Group type: EXPERIMENTAL
Intervention: Video Otoendoscopy (VO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard Microscopy (SM)
Number of subjects: 50
Study: 32875698

Group type: EXPERIMENTAL
Intervention: SPP muco‐periosteal flap
Number of subjects: 160

Group type: COMPARATOR
Intervention: EPP mucosa flap
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 35367525

Group type: EXPERIMENTAL
Intervention: Trametinib (1.0, 1.5, and 2.0 mg daily for 28 days) plus whole brain radiation therapy (WBRT, 37.5 Gy/15 fractions)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Trametinib plus WBRT
Number of subjects: 10
Study: 32414637

Group type: EXPERIMENTAL
Intervention: Attitudes toward AI
Number of subjects: 123
Study: 32587722

Group type: EXPERIMENTAL
Intervention: Multimedia training (film with text, audio, and animation presented as a multimedia CD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lecture training (four one-hour training sessions)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multimedia training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lecture training
Number of subjects: 120
Study: 36189534

Group type: EXPERIMENTAL
Intervention: Acacia nilotica paste
Number of subjects: 20

Group type: COMPARATOR
Intervention: Povidone iodine solution
Number of subjects: 20
Study: 33867382

Group type: EXPERIMENTAL
Intervention: Standing back extension exercise (fatigue-exercise group)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No exercise (fatigue-non-exercise group)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standing back extension exercise without fatigue task (non-fatigue-exercise group)
Number of subjects: 33
Study: 32562806

Group type: EXPERIMENTAL
Intervention: Image-and-text HWL
Number of subjects: 4134

Group type: EXPERIMENTAL
Intervention: Image-and-text HWL with calories
Number of subjects: 4134

Group type: EXPERIMENTAL
Intervention: Text-only HWL
Number of subjects: 4134

Group type: EXPERIMENTAL
Intervention: Text-only HWL with calories
Number of subjects: 4134

Group type: EXPERIMENTAL
Intervention: Calories only
Number of subjects: 4134

Group type: COMPARATOR
Intervention: No label
Number of subjects: 4134
Study: 36069869

Group type: EXPERIMENTAL
Intervention: Open-source automated insulin delivery (AID) system
Number of subjects: 97

Group type: COMPARATOR
Intervention: Sensor-augmented insulin pump (control)
Number of subjects: 97
Study: 36115668

Group type: EXPERIMENTAL
Intervention: Physiotherapy exercise rehabilitation with adherence support
Number of subjects: 116

Group type: COMPARATOR
Intervention: Physiotherapy exercise rehabilitation alone
Number of subjects: 116
Study: 32586437

Group type: EXPERIMENTAL
Intervention: CBIT (Comprehensive Behavioral Intervention for Tic Disorders)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CBIT
Number of subjects: 15
Study: 32335581

Group type: EXPERIMENTAL
Intervention: Blue LED light centered at 478 nm
Number of subjects: 98

Group type: COMPARATOR
Intervention: Blue LED light centered at 459 nm
Number of subjects: 98